Everest medicines to hold investor calls with updates on mrna therapeutic vaccine programs

Shanghai , feb. 28, 2025 /prnewswire/ -- everest medicines (hkex 1952.hk, "everest", or the "company"), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing transformative pharmaceutical products and vaccines, today announced that it will hold investor calls to discuss recent developments on its mrna therapeutic vaccine programs. the english session of the conference call will be held at 9:00 pm on march 6, 2025 beijing time (8:00 am u.s. eastern time on march 6), and the mandarin session of the conference call will be held at 9:00 am beijing time on march 7, 2025 (8:00 pm u.s. eastern time on march 6).
EG Ratings Summary
EG Quant Ranking